AZD2936 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-28 in 2mo
ESTIMATED |
READOUT
A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With
Phase 1/2 · Non-Small-Cell Lung Carcinoma |
AZN ASTRAZENECA PLC | AZD2936 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|